| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/14/2005 | US20050155091 Protein kinase gamma (Prkag3 ) regulator sequences for use as tool in directing heterologous gene expression and proteins for treatment of diabetes, obesity, insulin resistance and dyslipidemia |
| 07/14/2005 | US20050155088 Ralstonia ahl-acylase gene |
| 07/14/2005 | US20050154197 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/14/2005 | US20050153921 Methods of using mammalian RNase H and compositions thereof |
| 07/14/2005 | US20050153920 Ribozymes used as prodrugs |
| 07/14/2005 | US20050153893 Thrombin peptide derivative dimers |
| 07/14/2005 | US20050153884 Methods of therapy with thrombin derived peptides |
| 07/14/2005 | US20050153448 Fungal beta-glucuronidase genes and gene products |
| 07/14/2005 | US20050153418 Using ligand immobilized matrices to isolate preferential bacterial protease from mixtures; high preformance liquid chromatography |
| 07/14/2005 | US20050153417 Halohydrin dehalogenases and related polynucleotides |
| 07/14/2005 | US20050153416 Anticancer agents |
| 07/14/2005 | US20050153415 Lysin for use as tool in prevention of clostridial infection |
| 07/14/2005 | US20050153413 Type II thioesterase from streptomyces coelicolor a3(2) and the coding sequence |
| 07/14/2005 | US20050153412 Aldehyde dehydrogenase II |
| 07/14/2005 | US20050153407 Chemoenzymatic methods for the synthesis of statins and stain intermediates |
| 07/14/2005 | US20050153405 Such as 4-(Indol-3-ylmethyl)-4-hydroxy-2-oxoglutarate from indole pyruvic acid and pyruvic acid (and/or oxaloacetic acid) by aldolase derived from Pseudomonas, Erwinia, Flavobacterium, and/or Xanthomonas |
| 07/14/2005 | US20050153404 Anti-kazlauskas lipases |
| 07/14/2005 | US20050153402 Expression vector comprising nucleotide sequences coding metabolic regulatory (MR) proteins for use as tools which enhance exogenous gene expression; bioreactors; target construct for use in enhancing gene delivery to cells |
| 07/14/2005 | US20050153399 Introducing a DNA construct into a filamentous fungal cell, culturing the filamentous fungal cell under suitable culture conditions to allow expression of the heterologous DNA sequence, and producing the protease inhibitor |
| 07/14/2005 | US20050153397 Methods for producing polypeptides in Aspergillus mutant cells |
| 07/14/2005 | US20050153396 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/14/2005 | US20050153374 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |
| 07/14/2005 | US20050153348 Using membrane protein expression pattern as diagnostic and prognostic tool in detection of breast, colon and lung tissue cell proliferative disorders |
| 07/14/2005 | US20050153345 peptide of given amino acid sequence related to the related to the UDP-glycosyltransferase drug-metabolizing enzyme subfamily; use drug screening |
| 07/14/2005 | US20050153340 Ribonuclease for use as tool in treatment and prevention of metabolic disorders |
| 07/14/2005 | US20050153339 Modified shine-dalgarno sequences and methods of use thereof |
| 07/14/2005 | US20050153338 Using polymerase chain chimerization to direct evolution of enhanced biopolymer molecules; directed protein evolution |
| 07/14/2005 | US20050153334 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 07/14/2005 | US20050153331 Expression vector comprising nucleotide sequences coding sialic acid synthetase and/or aldolase for use in prevention and treatment of cell proliferative, immunological and muscular disorders |
| 07/14/2005 | US20050153323 Expression vector comprising nucleotide sequences coding aggrecanases for use in the identification of modulators for prevention and treatment of metabolic and mental disorders |
| 07/14/2005 | US20050153315 Nucleotide sequences coding polypeptide comprising methylarginase activities for use in identifying modulator for prevention and treatment of ischemia-reperfusion injuries, cancer, hypotension, multi-organ failure, arthritis, skin, inflammatory, cardiac and/or migraine disorders |
| 07/14/2005 | US20050153310 Luciferase biosensor |
| 07/14/2005 | US20050153307 PNA oligomers, oligomer sets, methods and kits pertaining to the determination of Enterococcus faecalis and other Enterococcus species |
| 07/14/2005 | US20050153303 Method of mutagenic chain reaction |
| 07/14/2005 | US20050153299 Expression vector comprising nucleotide sequences coding thermophilic bacterium polymerase subunit for use as replication tool during in vitro DNA amplification |
| 07/14/2005 | US20050153287 Nr3b nmda receptor subunit compositions and related methods |
| 07/14/2005 | US20050152888 in a ubiquitin-independent manner comprising complexing proteasome-localizing agents with polypeptides and allowing degradation of the polypeptide |
| 07/14/2005 | US20050152877 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS receptors |
| 07/14/2005 | DE10360841A1 Helle, stabile, staub- und geruchsarme Enzymgranulate Light, stable, dust and odor enzyme granules |
| 07/14/2005 | DE10357827A1 Preparing enzyme granules, useful in nutritional, cleaning and pharmaceutical compositions, by spraying enzyme solution into gas stream containing solid particles, followed by drying and granulation |
| 07/14/2005 | DE10315376B4 Verfahren zur Kultivierung des Nitrilhydratase-produzierenden Stammes RHODOCOCCUS RHODOCHROUS M33 Method for the cultivation of the nitrile hydratase producing strain RHODOCOCCUS rhodochrous M33 |
| 07/14/2005 | CA2805816A1 Transgenic plants expressing a putative palmitoyl protein thioesterase |
| 07/14/2005 | CA2804953A1 Plant activation of insect toxin |
| 07/14/2005 | CA2801848A1 Methods for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 07/14/2005 | CA2551011A1 Plant activation of insect toxin |
| 07/14/2005 | CA2550730A1 Method and compositions for identifying anti-hiv therapeutic compounds |
| 07/14/2005 | CA2550376A1 Novel carotenoids ketolases |
| 07/13/2005 | EP1553184A1 Process for producing tripeptide or higher peptide |
| 07/13/2005 | EP1553178A1 Tumor-lysing virus growing selectively in tumor cells |
| 07/13/2005 | EP1553175A1 Cephalosporin C acylase mutants |
| 07/13/2005 | EP1553174A2 Enzymes and detergent compositons |
| 07/13/2005 | EP1553173A2 Enzymes and detergent compositions |
| 07/13/2005 | EP1553172A1 Thermostable ribonuclease |
| 07/13/2005 | EP1553171A1 Novel enzyme forming peptide, microorganism producing the same and process for producing dipeptide using them |
| 07/13/2005 | EP1553170A1 Novel carbonyl reductase, gene thereof and method of using the same |
| 07/13/2005 | EP1552847A1 Inhibitors for continuous activation of calcineurin |
| 07/13/2005 | EP1552846A2 Use of heparinases to decrease inflammatory responses |
| 07/13/2005 | EP1552740A1 Chimeric murine model comprising human hepatocytes - use for screening compounds |
| 07/13/2005 | EP1552310A2 Diagnostic and therapeutic use of the nicotinamide mononucleotide adenylyltransferase 2 (nmnat-2) gene and protein for neurodegenerative diseases |
| 07/13/2005 | EP1551987A1 Protein modification |
| 07/13/2005 | EP1551976A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 07/13/2005 | EP1551975A2 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 07/13/2005 | EP1551966A2 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
| 07/13/2005 | EP1551965A2 Short enzyme donor fragment |
| 07/13/2005 | EP1551964A2 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 07/13/2005 | EP1551963A1 Improved immunotherapy |
| 07/13/2005 | EP1551962A2 Mitotic kinesin binding site |
| 07/13/2005 | EP1551927A1 Biological active coating components, coatings, and coated surfaces |
| 07/13/2005 | EP1551858A2 Dna and amino acid sequences of a tyrosine ammonia lyase enzyme from the bacterium rhodobacter sphaeroides |
| 07/13/2005 | EP1551756A1 Oxygen scavenging system |
| 07/13/2005 | EP1551218A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 07/13/2005 | EP1430143A4 Stabilization of t4 endonuclease v |
| 07/13/2005 | EP0553234B2 Luciferase compositions and methods |
| 07/13/2005 | CN1639571A Population based assessments and means to rank the relative immunogenicity of proteins |
| 07/13/2005 | CN1639416A Use of lipolytic enzymes for stickies control |
| 07/13/2005 | CN1639349A Microorganisms and processes for enhanced production of pantothenate |
| 07/13/2005 | CN1639347A Process for producing levodione |
| 07/13/2005 | CN1639345A LIS promoter for expression of transgenes in floral tissues |
| 07/13/2005 | CN1639344A A method of selectively producing male or female sterile plants |
| 07/13/2005 | CN1639343A Method for detection of leptin receptor ligands |
| 07/13/2005 | CN1639341A Process for producing L-threonine with the use of bacterium belonging to the genus escherichia |
| 07/13/2005 | CN1639340A Method of controlling ethanol production |
| 07/13/2005 | CN1639339A Fermentation process |
| 07/13/2005 | CN1639337A Protein or polypeptide having lachrymator synthase activity, DNA encoding the protein or the polypeptide, process for producing protein or polypeptide having lachrymator synthase activity using the DN |
| 07/13/2005 | CN1639329A Selective enzymatic esterification and solvolysis of epimeric vitamin D analog and separation of the epimers |
| 07/13/2005 | CN1639328A Novel dehydrogenase and gene encoding the same |
| 07/13/2005 | CN1639324A Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 07/13/2005 | CN1639183A Secretion, transcription and sporulation genes in bacillus clausii |
| 07/13/2005 | CN1638808A Coupling proteins to a modified polysaccharide |
| 07/13/2005 | CN1638655A Modifying nicotine and nitrosamine levels in tobacco |
| 07/13/2005 | CN1638622A Heat stable mutants of starch biosynthesis enzymes |
| 07/13/2005 | CN1637146A Method for synthesizing DNA |
| 07/13/2005 | CN1637144A P450BM-3Glu435 Asp varient gene capable of catalyzing indole to generate indigo blue and its use |
| 07/13/2005 | CN1637143A Correlation gene for generating synthetic cholesterol synthetic inhibitor monakalin k |
| 07/13/2005 | CN1637141A Cytochrome P450BM-3 monooxygehase varient gene and its use |
| 07/13/2005 | CN1636597A Compounds for the treatment of female sexual dysfunction |
| 07/13/2005 | CN1636594A Angiostatin and use of the same for inhibition of angiogenesis |
| 07/13/2005 | CN1210404C Acetohydroacid synthase promoter for expression of introduced genes in plants |
| 07/13/2005 | CN1210403C Method for producing biotin |
| 07/13/2005 | CN1210398C Superoxide dismutase conjugated substance and preparation method thereof |